Filing Details
- Accession Number:
- 0001415889-12-001793
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-29 20:36:59
- Reporting Period:
- 2012-11-27
- Filing Date:
- 2012-11-29
- Accepted Time:
- 2012-11-29 20:36:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070494 | Acadia Pharmaceuticals Inc | ACAD | Pharmaceutical Preparations (2834) | 061376651 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1487100 | Glenn Baity | 3911 Sorrento Valley Blvd San Diego CA 92121 | Vp And Gc | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-11-27 | 16,206 | $6.28 | 47,559 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-28 | 4,396 | $5.25 | 43,163 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2012.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.03 to $6.50 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 4 to this Form 4.
- Includes an aggregate of 39,559 shares acquired by Mr. Baity under the ACADIA Pharmaceuticals Employee Stock Purchase Plan since inception.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.26 per share, inclusive.
Billionaire Hedge Funds
